MADHAVBAUG — Vaidya Sane Ayurved Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.55bn
- IN₹1.38bn
- IN₹990.25m
Annual cashflow statement for Vaidya Sane Ayurved Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 8.82 | -4.47 | 16.1 | 47.6 | 69.1 |
| Depreciation | |||||
| Non-Cash Items | 5.7 | 9.33 | 5.69 | 0.4 | -2.99 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.6 | 50.1 | 11.5 | -202 | -96.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 15.8 | 77.2 | 57.8 | -131 | -4.29 |
| Capital Expenditures | -89.7 | -38.5 | -6.81 | -31.7 | -69.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -10.8 | -0.819 | 2.71 | -45.4 | 79.8 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -101 | -39.3 | -4.1 | -77.1 | 9.99 |
| Financing Cash Flow Items | -5.67 | -9.36 | -5.69 | 189 | -1.88 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 77.1 | -36.3 | -55.2 | 225 | -13.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.64 | 1.56 | -1.55 | 16.6 | -8.09 |